Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.906
+0.046 (2.47%)
At close: Sep 5, 2025, 4:00 PM
1.850
-0.056 (-2.94%)
Pre-market: Sep 8, 2025, 8:50 AM EDT

APUS Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8.7400.410.010.17
Cash & Short-Term Investments
8.7400.410.010.17
Cash Growth
13694.21%-99.16%6551.77%-96.40%-
Prepaid Expenses
1.610.010.01-0
Total Current Assets
10.350.010.420.010.17
Total Assets
10.550.010.420.010.17
Accounts Payable
0.01---0.01
Accrued Expenses
0.070.70.120.04-
Short-Term Debt
0.50.33-0.28-
Current Income Taxes Payable
---0-
Total Current Liabilities
0.811.020.120.320.01
Long-Term Debt
-0.350.270.40.4
Total Liabilities
0.811.370.390.720.41
Common Stock
0.130.080.080.10.1
Additional Paid-In Capital
17.072.952.951.411.22
Retained Earnings
-7.46-4.39-3-2.22-1.56
Shareholders' Equity
9.74-1.360.03-0.71-0.24
Total Liabilities & Equity
10.550.010.420.010.17
Total Debt
0.50.670.270.680.4
Net Cash (Debt)
8.24-0.670.14-0.68-0.23
Net Cash Per Share
0.97-0.080.03-0.18-0.06
Filing Date Shares Outstanding
12.588.197.95.773.85
Total Common Shares Outstanding
12.587.97.95.773.85
Working Capital
9.54-1.010.3-0.310.16
Book Value Per Share
0.77-0.170.00-0.12-0.06
Tangible Book Value
9.74-1.360.03-0.71-0.24
Tangible Book Value Per Share
0.77-0.170.00-0.12-0.06
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q